A Phase II, Single-Arm Study of Apatinib and Oral Etoposide in Heavily Pre-Treated Metastatic Breast Cancer

INTRODUCTION: We performed this clinical trial to evaluate the efficacy and safety of apatinib and oral etoposide in patients with HER2-negative locally advanced or metastatic breast cancer (MBC). METHODS: Patients with HER2-negative MBC previously treated with anthracycline and taxanes and failed ≥...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Nanlin, Zhu, Anjie, Si, Yiran, Yue, Jian, Wang, Xue, Wang, Jiayu, Ma, Fei, Xu, Binghe, Yuan, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917213/
https://www.ncbi.nlm.nih.gov/pubmed/33659204
http://dx.doi.org/10.3389/fonc.2020.565384

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917213/
https://www.ncbi.nlm.nih.gov/pubmed/33659204
http://dx.doi.org/10.3389/fonc.2020.565384

Ejemplares similares